Skip to main content
Clinical Trials/CTIS2022-502059-79-00
CTIS2022-502059-79-00
Active, not recruiting
Phase 1

StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack

Amsterdam UMC0 sites1,200 target enrollmentOctober 13, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Amsterdam UMC
Enrollment
1200
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • Age \= 70 years or older at the time of ischemic stroke or TIA; inclusion within 6 weeks after diagnosis of ischemic stroke or TIA; frailty as defined by a pre\-event score of 4\-7 and/or post\-event score of 6\-7 on the validated Clinical Frailty Scale.

Exclusion Criteria

  • Very severe frailty or very limited life expectancy (\< 6 months) as defined by a score \>\= 8 points on the validated Clinical Frailty Scale; a previous serious adverse drug reaction to statins; not speaking Dutch; being unable to answer questions and have no proxy assessment available; being unable or not willing to give written informed consent (either patient or patient with help from proxy).

Outcomes

Primary Outcomes

Not specified

Similar Trials